NBC News @NBCNews
The results, published in the New England Journal of Medicine, suggest that the new treatment had fewer side effects than Paxlovid, the go-to antiviral for high-risk patients. https://t.co/T6CEYWT5NQ — PolitiTweet.org
Created
Fri Dec 30 00:32:05 +0000 2022
Likes
66
Retweets
21
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
NBC News @NBCNews
The results, published in the New England Journal of Medicine, suggest that the new treatment had fewer side effects than Paxlovid, the go-to antiviral for high-risk patients. https://t.co/T6CEYWT5NQ — PolitiTweet.org